Compare Badger Meter Inc (BMI) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Badger Meter Inc vs Neurocrine Biosciences Inc — how do they compare? Badger Meter Inc trades at $141.46 (market cap $4.13B), while Neurocrine Biosciences Inc trades at $170.05 (market cap $17.30B). The key difference: Neurocrine Biosciences Inc is far larger — about 4.2× Badger Meter Inc's market cap, and Badger Meter Inc pays a 1.13% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| BMI | NBIX | |
|---|---|---|
Market Cap | $4.13B | $17.30B |
Sector | Technology | Health |
52-Week High | $245.81 | $180.55 |
52-Week Low | $113.41 | $123.10 |
Enterprise Value | $3.92B | $16.39B |
Dividend Yield | 1.13% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Badger Meter Inc
Badger Meter provides industry-leading water management solutions. Its smart measurement hardware and software analytics help water utilities and industrial customers optimize operations and conserve natural resources.
Read more on BMI →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
